Maple Wang

6.3k total citations · 4 hit papers
9 papers, 1.9k citations indexed

About

Maple Wang is a scholar working on Infectious Diseases, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Maple Wang has authored 9 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 3 papers in Molecular Biology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Maple Wang's work include SARS-CoV-2 and COVID-19 Research (8 papers), Viral gastroenteritis research and epidemiology (3 papers) and COVID-19 Clinical Research Studies (3 papers). Maple Wang is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), Viral gastroenteritis research and epidemiology (3 papers) and COVID-19 Clinical Research Studies (3 papers). Maple Wang collaborates with scholars based in United States, Hong Kong and Canada. Maple Wang's co-authors include David D. Ho, Jian Yu, Lihong Liu, Yaoxing Huang, Yicheng Guo, Zizhang Sheng, Sho Iketani, Manoj S. Nair, Harris H. Wang and Yiming Huang and has published in prestigious journals such as Nature, Cell and Science Translational Medicine.

In The Last Decade

Maple Wang

9 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants

2022 495 citations Qian Wang, Sho Iketani et al. Cell profile →
Antibody evasion properties of SARS-CoV-2 Omicron sublineages

2022 478 citations Sho Iketani, Lihong Liu et al. Nature profile →
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5

2022 433 citations Qian Wang, Yicheng Guo et al. Nature profile →
Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization

2021 390 citations Pengfei Wang, Ryan G. Casner et al. Cell Host & Microbe profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maple Wang United States	7	1.7k	515	243	207	157	9	1.9k
Paul W. Rothlauf United States	9	1.7k 1.0×	535 1.0×	240 1.0×	184 0.9×	206 1.3×	12	2.0k
Amy Kempf Germany	12	1.5k 0.9×	380 0.7×	206 0.8×	134 0.6×	160 1.0×	27	1.6k
Luise Graichen Germany	10	1.4k 0.8×	356 0.7×	210 0.9×	130 0.6×	146 0.9×	21	1.6k
Sho Iketani United States	18	1.9k 1.1×	673 1.3×	286 1.2×	214 1.0×	236 1.5×	25	2.3k
Qiyu Sun China	14	1.5k 0.9×	637 1.2×	272 1.1×	138 0.7×	174 1.1×	25	2.0k
Ray T. Y. So Hong Kong	9	1.2k 0.7×	345 0.7×	215 0.9×	209 1.0×	135 0.9×	17	1.4k
Frauke Muecksch United States	12	1.3k 0.8×	322 0.6×	151 0.6×	164 0.8×	198 1.3×	20	1.5k
Anthony Bowen United States	14	1.0k 0.6×	392 0.8×	147 0.6×	256 1.2×	192 1.2×	22	1.4k
Zhiteng Li China	11	998 0.6×	370 0.7×	164 0.7×	135 0.7×	132 0.8×	32	1.3k
Inga Nehlmeier Germany	22	1.3k 0.8×	471 0.9×	204 0.8×	129 0.6×	306 1.9×	49	1.9k

Countries citing papers authored by Maple Wang

Since Specialization

Citations

This map shows the geographic impact of Maple Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maple Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maple Wang more than expected).

Fields of papers citing papers by Maple Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maple Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maple Wang. The network helps show where Maple Wang may publish in the future.

Co-authorship network of co-authors of Maple Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Maple Wang. A scholar is included among the top collaborators of Maple Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maple Wang. Maple Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Aschner, Clare Burn, Krithika Muthuraman, Iga Kucharska, et al.. (2023). A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo. Science Translational Medicine. 15(697). eadf4549–eadf4549. 11 indexed citations

2.

Nair, Manoj S., Ruy M. Ribeiro, Maple Wang, et al.. (2023). Changes in serum-neutralizing antibody potency and breadth post-SARS-CoV-2 mRNA vaccine boost. iScience. 26(4). 106345–106345. 3 indexed citations

3.

Sheng, Zizhang, Jude Bimela, Maple Wang, et al.. (2023). An optimized thermodynamics integration protocol for identifying beneficial mutations in antibody design. Frontiers in Immunology. 14. 1190416–1190416. 2 indexed citations

4.

Iketani, Sho, Lihong Liu, Yicheng Guo, et al.. (2022). Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature. 604(7906). 553–556. 478 indexed citations breakdown →

5.

Wang, Qian, Yicheng Guo, Sho Iketani, et al.. (2022). Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5. Nature. 608(7923). 603–608. 433 indexed citations breakdown →

6.

Wang, Qian, Sho Iketani, Zhiteng Li, et al.. (2022). Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. Cell. 186(2). 279–286.e8. 495 indexed citations breakdown →

7.

Cerutti, Gabriele, Yicheng Guo, Pengfei Wang, et al.. (2021). Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain. Cell Reports. 37(5). 109928–109928. 42 indexed citations

8.

Wang, Pengfei, Ryan G. Casner, Manoj S. Nair, et al.. (2021). Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell Host & Microbe. 29(5). 747–751.e4. 390 indexed citations breakdown →

9.

Wang, Pengfei, Ryan G. Casner, Manoj S. Nair, et al.. (2021). A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses. Emerging Microbes & Infections. 11(1). 147–157. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact